These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8516813)

  • 1. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.
    Starzl TE; Demetris AJ; Trucco M; Zeevi A; Ramos H; Terasaki P; Rudert WA; Kocova M; Ricordi C; Ildstad S
    Transplantation; 1993 Jun; 55(6):1272-7. PubMed ID: 8516813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.
    Strober S; Benike C; Krishnaswamy S; Engleman EG; Grumet FC
    Transplantation; 2000 Apr; 69(8):1549-54. PubMed ID: 10836360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine.
    Rosengard BR; Ojikutu CA; Guzzetta PC; Smith CV; Sundt TM; Nakajima K; Boorstein SM; Hill GS; Fishbein JM; Sachs DH
    Transplantation; 1992 Sep; 54(3):490-7. PubMed ID: 1412729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of microchimerism in recipients 15 years after living related kidney transplantation.
    Ishida H; Kawai T; Tanabe K; Hayasaka Y; Yasuo M; Toma H; Ota K
    Transplantation; 1996 Jul; 62(1):126-8. PubMed ID: 8693527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.
    Kawai T; Cosimi AB; Colvin RB; Powelson J; Eason J; Kozlowski T; Sykes M; Monroy R; Tanaka M; Sachs DH
    Transplantation; 1995 Jan; 59(2):256-62. PubMed ID: 7839449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.
    Thomas JM; Carver FM; Kasten-Jolly J; Haisch CE; Rebellato LM; Gross U; Vore SJ; Thomas FT
    Transplantation; 1994 Jan; 57(1):101-15. PubMed ID: 8291095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.
    Burlingham WJ; Grailer AP; Fechner JH; Kusaka S; Trucco M; Kocova M; Belzer FO; Sollinger HW
    Transplantation; 1995 Apr; 59(8):1147-55. PubMed ID: 7732562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migratory nonparenchymal cells after organ allotransplantation: with particular reference to chimerism and the liver.
    Starzl TE; Demetris AJ; Rao AS; Thomson AW; Trucco M; Murase N
    Prog Liver Dis; 1994; 12():191-213. PubMed ID: 7746875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
    Jin MX; Engelstad K; Oluwole SF
    Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.